Vanguard Global Advisers
LMAT icon

Vanguard Global Advisers’s LeMaitre Vascular LMAT Stock Holding History

Vanguard Global Advisers’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$768K Sell
8,003
-459
-5% -$47.1K ﹤0.01% 1893
2026
Q1 		$924K Buy
+8,462
New +$807K ﹤0.01% 1698

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Global Advisers's LMAT Position: Q2 2026 in Review

Vanguard Global Advisers reduced its LeMaitre Vascular (LMAT) stake by 5.4% in Q2 2026, selling an estimated $47.1K and leaving 8,003 shares worth $768K. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

Vanguard Global Advisers first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $924K in Q1 2026. 323 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Vanguard Global Advisers held 8,003 shares of LeMaitre Vascular worth $768K as of Q2 2026.
  • Vanguard Global Advisers sold 459 LeMaitre Vascular shares in Q2 2026, an estimated $47.1K.
  • LeMaitre Vascular made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1893 holding.
  • Vanguard Global Advisers first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's LeMaitre Vascular position peaked at $924K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.